At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
tDCSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Efficacy of Neural Stimulation in Individuals With Schizophrenia
In Brief
A clinical study evaluating tDCS for Schizophrenia and Schizo Affective Disorder. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The purpose of this study is to understand the relationship between psychotic symptoms and social functioning in individuals with schizophrenia spectrum disorders. Our goal is to determine whether stimulating the brain using transcranial Direct Current Stimulation (tDCS) can improve symptoms and daily functioning.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia, Schizo Affective Disorder
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartNov 2022
First PostedFeb 2023
Primary CompletionAug 2024
TodayJul 2026
First PostedFeb 27, 2023
Enrollment StartNov 21, 2022
Primary CompletionAug 1, 2024
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 3.3 years ago
Interventions
tDCSdevice
active anodal tDCS and sham tDCS